The discovery of CA-KR1, a highly thermo- and alkali-stable carbonic anhydrase, signifies a leap forward toward the facilitation of biomimetic HPC carbon ...
sialidosis type 1 or juvenile adult galactosialidosis and Gaucher disease type III. The drug candidate is administered orally as a capsule. The drug candidate targets glucosylceramide synthase (GCS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback